Navigation Links
Predictability: The brass ring for synthetic biology
Date:3/14/2013

Predictability is often used synonymously with "boring," as in that story or that outcome was soooo predictable. For practioners of synthetic biology seeking to engineer valuable new microbes, however, predictability is the brass ring that must be captured. Researchers with the multi-institutional partnership known as BIOFAB have become the first to grab at least a portion of this ring by unveiling a package of public domain DNA sequences and statistical models that greatly increase the reliability and precision by which biological systems can be engineered.

The DNA sequences produced by BIOFAB provide precise control of gene expression in Escherichia coli, the rod-shaped bacterium that is one of the principal model organisms for genetic engineering. While these DNA sequences serve as standardized parts specific to E. coli, they also provide a set of rules for how the sequences fit together that should apply to other microbes as well. Controlling the expression of genes is essential for engineering a microbe to produce a specific product or carry out a specific function.

As BIOFAB co-director Adam Arkin, a computational biologist and director of Berkeley Lab's Physical Biosciences Division, has noted, "Fulfilling the great promise of synthetic biology hinges on making the design and construction of biological systems as predictable as the assembly of computer hardware."

Yet even with a microbe as well-characterized and understood as E. coli, the introduction of new genes has in the past been met with as much failure as success.

"You would think after a generation of genetic engineering, expressing genes with precision in an organism as well utilized as E. coli would be pretty straightforward but it's not," says BIOFAB's other co-director Drew Endy, a synthetic biologist at Stanford University.

Arkin and Endy are the corresponding authors of a pair of research papers published simultaneously in the journal Nature Methods, and a third to be published in Nucleic Acids Research, that collectively describe this major BIOFAB breakthrough.

BIOFAB's success is based on two major achievements - the design of independent DNA promoter and ribosome binding site sequences for specific E. coli genes, and the development of mathematical models that provide rules for engineering gene expression that should be applicable to nearly all organisms. This work establishes a much-needed technological foundation for the field of synthetic biology, which in turn should facilitate more precise and predictable genetic engineering in the future.


'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Related biology news :

1. Synthetic molecule first electricity-making catalyst to use iron to split hydrogen gas
2. Synthetic Biologics to Present at the 2013 BIO CEO & Investor Conference
3. Developing microbial cell factories by employing synthetic small regulatory RNAs
4. Oscillating gel gives synthetic materials the ability to speak
5. Synthetic and biological nanoparticles combined to produce new metamaterials
6. New report finds increase in media coverage of synthetic biology
7. Synthetic fuel could eliminate US need for crude oil
8. Microchoreography: Researchers use synthetic molecule to guide cellular dance
9. Nottingham part of £20m investment for UK synthetic biology
10. Synthetic biofilter wins through to the top Sweet 16 in Boston
11. Collagen-seeking synthetic protein could lead doctors to tumor locations
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Predictability: The brass ring for synthetic biology
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ROTTERDAM, the Netherlands and LAGUNA HILLS, ... that The Institute of Cancer Research, London ... will use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify ... high-risk trial known as MUK nine . The University ... this trial, which is partly funded by Myeloma UK, and ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology: